NCT02968810 2026-03-18
Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis
National Cancer Institute (NCI)
Phase 2 Active not recruiting
Clinical Trials
12 trialsNCT06096779 2026-03-06
Kirros
Genentech, Inc.
Phase 2 Recruiting
NCT04485286 2026-02-27
Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue Injury
Massachusetts General Hospital
Phase 2 Recruiting
NCT05027425 2024-11-22
Durvalumab (MEDI4736) and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver Transplant
University of Cincinnati
Phase 2 Active not recruiting
NCT05637216 2024-09-03
Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients
Shaw Cancer Center
Phase 2 Recruiting
NCT03908255 2022-01-28
BCAA in HCC
Louisiana State University Health Sciences Center in New Orleans
Phase 2 Withdrawn
NCT01981850 2022-01-05
A Phase 2 Study of RO7490677 In Participants With Myelofibrosis
Hoffmann-La Roche
Phase 2 Completed
NCT01562821 2017-01-13
Safety and Efficacy of Activated Recombinant Human Factor VII in Cirrhotic Patients Undergoing Partial Hepatectomy
Novo Nordisk A/S
Phase 2 Completed
NCT01215565 2014-03-13
Fibrolam
Assistance Publique - Hôpitaux de Paris
Phase 2 Terminated
NCT00780312 2013-07-02
HOHF
Rigshospitalet, Denmark
Phase 2 Completed
NCT01822405 2013-04-02
ORT-OXI-2009
Hospital Universitario de Canarias
Phase 2 Unknown
NCT00583700 2013-01-29
Trental & Vitamin E for Radiation-Induced Fibrosis
University of Iowa
Phase 2 Completed